Point72 Middle East FZE’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-22	Closed	-$1.59K	–	1290
2023 Q1	$1.59K	Buy	+22	New	+$1.59K	﹤0.01%	1000